Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  GenSight Biologics S.A.    SIGHT   FR0013183985

GENSIGHT BIOLOGICS S.A.

(SIGHT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization1 14482,481,1301--
Entreprise Value (EV)1 91,559,673,5284306307
P/E ratio -5,62x-2,43x-2,30x-12,8x-15,6x-36,1x
Yield ------
Capitalization / Revenue 38,9x19,2x16,6x24,1x19,2x20,0x
EV / Revenue 24,7x13,8x15,0x22,8x19,6x20,5x
EV / EBITDA -3,85x-1,82x-2,51x-17,9x-24,5x-62,1x
Price to Book 2,46x3,41x6,93x-10,4x-4,52x-3,65x
Nbr of stocks (in thousands) 23 29024 73032 65339 608--
Reference price (EUR) 6,183,332,497,597,597,59
Last update 02/28/201804/24/201903/12/202010/22/202010/22/202010/22/2020
1 EUR in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales1 3,704,304,9012,515,615,0
EBITDA1 -23,8-32,7-29,3-15,9-12,5-4,95
Operating profit (EBIT)1 -24,0-33,0-30,3-16,1-13,2-5,10
Operating Margin -649%-767%-618%-129%-84,1%-34,0%
Pre-Tax Profit (EBT)1 --33,5-30,7-13,0-5,00-1,00
Net income1 -24,1-33,5-30,7-16,7-16,1-6,25
Net margin -651%-779%-627%-134%-103%-41,7%
EPS2 -1,10-1,37-1,08-0,59-0,49-0,21
Dividend per Share ------
Last update 02/28/201804/24/201903/12/2020---
1 EUR in Million
2 EUR
Estimates
Balance Sheet Analysis
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt1 ----5,156,85
Net Cash position1 52,422,87,6716,7--
Leverage (Debt / EBITDA) 2,21x0,70x0,26x1,05x-0,41x-1,38x
Free Cash Flow1 -19,0-29,2-28,2-12,6-21,1-8,45
ROE (Net Profit / Equities) -44,5%-84,8%-172%---
Shareholders' equity1 54,139,517,8---
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share2 2,510,980,36-0,73-1,68-2,08
Cash Flow per Share -0,86-1,16-0,99---
Capex1 0,240,790,070,551,151,80
Capex / Sales 6,38%18,3%1,41%4,41%7,36%12,0%
Last update 02/28/201804/24/201903/12/202010/22/202010/22/202010/22/2020
1 EUR in Million
2 EUR
Estimates
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (EUR)
300 621 000
Capitalization (USD)
359 293 654
Net sales (EUR)
4 900 000
Net sales (USD)
5 896 709
Number of employees
25
Sales / Employee (EUR)
196 000
Sales / Employee (USD)
235 868
Free-Float
95,4%
Free-Float capitalization (EUR)
286 880 573
Free-Float capitalization (USD)
342 871 487
Avg. Exchange 20 sessions (EUR)
6 946 230
Avg. Exchange 20 sessions (USD)
8 359 163
Average Daily Capital Traded
2,31%
EPS & Dividend